Maynooth University research reveals cancer-killing benefits of popular obesity treatment
Findings from the Londsdale Human Health Institute at Maynooth University in relation to GLP-1 obesity treatment showcase its ability to restore the body’s natural cancer-killing defences
2023-05-09
(Press-News.org)
Maynooth University’s Kathleen Londsdale Institute for Human Health Research has just published ground-breaking research into the benefits of the popular obesity treatment drug, GLP-1.
Previous research has found that people with obesity are at a greater risk of developing cancer, in part due to their anticancer immune cell -- better known as the ‘Natural Killer (NK)’ cell -- being rendered useless due to their disease.
New Health Research Board (HRB) funded research carried out by Dr Andrew Hogan and his team in the Londsdale Health Institute at Maynooth University, has found that the popular, and gold-standard pharmacological treatment for obesity, Glucagon-like peptide (GLP-1) analogues, can actually restore the NK cell function in the body including its ability to kill cancerous cells.
The World Health Organisation estimates that 13% of the global adult population suffers from obesity; a disease linked with a higher risk of getting cancer. These cancers make up 40% of all cancers diagnosed in the United States each year.
The research, published in Obesity, the Obesity Society’s Research Journal, one of the world’s leading peer-reviewed obesity journals, also shows that the restored cancer-killing effect of NK cells is independent of the GLP-1’s main weight loss function so it appears the treatment is directly kick-starting the NK cells’ engine.
Dr Andrew E. Hogan, Associate Professor & Principal Investigator, Lonsdale Human Health Institute in Maynooth University discussed the findings: “My team and I are very excited by these new findings in relation to the effects of the GLP-1 treatment on people with obesity and it appears to result in real tangible benefits for those currently on the drug.
“While these findings will understandably be welcomed by those living with obesity and looking for safe and effective treatments, given the recent spike in popularity related to the benefits of the GLP-1 treatment with global and high-profile celebrities commenting on its success, global demand has increased and resulted in a worldwide shortage of the drug.
"I hope this is something that is brought under control to ensure as many people as possible living with obesity can start their own treatment of this beneficial drug.”
Conor de Barra, PhD student in immunology at Maynooth University and Irish Research Council Scholar, who led the work in Dr Hogan’s lab said: “People with obesity can develop a variety of health problems like type 2 diabetes, sleep apnoea and cancer. These can have very negative impacts on their quality of life. This research and other promising findings on improvements in cardiovascular health after GLP-1 therapy indicate its potential benefits in addition to weight-loss.”
Prof Donal O’Shea, HSE National Lead for Obesity & Principal Investigator, said: “We are finally reaching the point where medical treatments for the disease of obesity are being shown to prevent the complications of having obesity. The current findings represent very positive news for people living with obesity on GLP-1 therapy and suggest the benefits of this family of treatments may extend to a reduction in cancer risk.”
Dr Hogan will present these findings at the 30th European Congress on Obesity, which will be held in Dublin on 20th of May.
END
ELSE PRESS RELEASES FROM THIS DATE:
2023-05-09
The touch of another person may increase levels of the “feelgood” hormone oxytocin. But the context really matters. The situation impacts oxytocin levels not only in the moment, but also later, as is shown by researchers at Linköping University and the University of Skövde in Sweden. Their study has been published in the scientific journal eLife.
An embrace from a parent, a warm hand on your shoulder or a caress from a romantic partner are examples of how touch can strengthen social bonds between people and influence emotions. ...
2023-05-09
Carbapenem-resistant Acinetobacter baumannii (CRAB) was brought into the ICU, in Hangzhou, on multiple occasions as patients were admitted, creating a large ‘reservoir’ of the bacteria which contaminated beds and equipment.
Of 35 CRAB-positive patients in the study, 14 acquired CRAB during their ICU stay. Samples of the drug-resistant bacteria were found more frequently in bed unit environments (54·6%) than patients (24·1%), with ventilators (27·9%) and dispensing trolleys (25·6%) most likely to yield samples of CRAB.
Publishing their findings today (Date ...
2023-05-09
The emergence and global spread of antimicrobial resistant bacteria among companion animals (e.g., dogs and cats) pose a risk of the animals being reservoirs for cross-species transmission because of their close contact with humans.
In Japan, for the first time, a research team led by Associate Professor Mayo Yasugi from the Osaka Metropolitan University Graduate School of Veterinary Science discovered Escherichia coli resistant to both colistin and third-generation cephalosporin antibiotics in a companion dog. Outside Japan, both colistin ...
2023-05-09
CHICAGO (May 9, 2023) — Four in 10 posts about liver disease on TikTok contain misinformation, with most pushing inaccurate claims about fad diets, “detox” drinks and herbal remedies, according to a study being presented today at Digestive Disease Week® (DDW) 2023. Results suggest that liver disease patients who seek medical information on TikTok may need help separating good information from the bad.
“People should always consult their doctor first for guidance on their specific medical condition, but we also know that getting health information and tips from social media is extremely common these days,” ...
2023-05-09
Metabolic syndrome with heavy alcohol use may have contributed to recent surge in alcoholic liver disease-related mortality
Abstract: https://www.acpjournals.org/doi/10.7326/M23-0518
URL goes live when the embargo lifts
A brief research report evaluating the relationship between metabolic syndrome (MetS) and a recent increase in alcohol-associated liver disease (ALD) deaths has found that heavy alcohol use and the presence of MetS was associated with a higher risk for advanced liver disease. This association may provide some explanation ...
2023-05-09
BATON ROUGE – Does altitude play a role in weight loss? Why is it easier to lose weight in Colorado versus Louisiana? Researchers at the Pennington Biomedical Research Center are seeking answers to these questions through one of the latest research trials, the “Low Oxygen and Weight Status,” or LOWS study. The LOWS study will determine whether exposure to low oxygen levels in the air, similar to those at higher altitudes, can help individuals with obesity lose weight and improve health.
The LOWS study is now open for participant enrollment. Participants will be randomized to ...
2023-05-09
Eight low-cost and easily implementable proven interventions for pregnant women in 81 low- and middle-income countries (LMICs) could prevent an estimated 566,000 stillbirths and 5.2 million babies a year from being born preterm or small for gestational age—some with low birth weight—the impacts of which would also affect long-term health and economic output, says a new four-paper Series published in The Lancet.
Additionally, the eight interventions,
multiple micronutrient supplements
balanced protein energy supplements
aspirin
treatment of syphilis
education for smoking cessation
prevention of malaria in pregnancy
treatment ...
2023-05-09
Sophia Antipolis, 9 May 2023: Adults in their 20s and 30s with mental disorders have an up to three-fold elevated likelihood of a heart attack or stroke, according to a study in more than 6.5 million individuals published today in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC).1 Lifestyle behaviours did not explain the excess risk. One in every eight of the 20-to-39-year-old participants had some kind of mental illness including depression, anxiety and insomnia.
“Psychological problems were common in young adults and had strong ...
2023-05-09
Grown in labs, human brain organoids are cultivated from stem cells, feed on nutrient broth and serve as a model of human brain development in miniature. Their growth and structure mimic portions of real brains, allowing scientists to better investigate the origins and potential treatments of neural diseases. How similar are they to actual human brains, though? Are they close enough to be considered people in their own right?
The question is complicated in myriad ethical and moral ways, but researchers based in Japan and Taiwan propose that the legal lens may prove critical when understanding the potential personhood of human ...
2023-05-09
New research has discovered that some patients with motor neuron disease (MND) and frontotemporal dementia (FTD) carry the same rare genetic defects that cause other neurodegenerative diseases.
Researchers from the Macquarie University MND Research Centre and The Walter and Eliza Hall Institute of Medical Research have identified the defects in the genomes of some people with non-inherited, or sporadic, MND and FTD.
MND results in the death of the neurons, or motor nerves, connecting the brain and spinal cord to the muscles. These are the cells that control our ability to move, breathe and swallow. The disease ...
LAST 30 PRESS RELEASES:
[Press-News.org] Maynooth University research reveals cancer-killing benefits of popular obesity treatment
Findings from the Londsdale Human Health Institute at Maynooth University in relation to GLP-1 obesity treatment showcase its ability to restore the body’s natural cancer-killing defences
